| David Askenazi, MD, MSPH Birmingham, AL USA Dr. Askenazi is the Medical Director of the Pediatric and Infant Center for Acute Nephrology (PICAN), whose mission is to improve the outcomes of infants and children at risk for acute kidney disease by performing excellent comprehensive multi-disciplinary care, research and education. Dr. Askenazi's research interest include: a) the role that acute kidney injury (AKI) has on short and long-term outcomes in neonates and pediatric patients, b) testing therapies to improve the short and long-term outcomes of neonates and pediatric patients with AKI, and c) improving the definition of neonatal AKI using urinary and serum biomarkers of AKI. Dr. Askenazi is the board chair of the Neonatal Kidney Collaborative and is the CSO for ZorroFlow.
.
|